Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Life360, Inc. director Charles J. Prober reported an option exercise and share sale in the company’s stock. On January 13, 2026, he exercised a stock option for 7,930 shares of common stock at an exercise price of $11.18 per share, then sold the same 7,930 shares at a price of $61.98 per share. After these transactions, he directly owned 105,456 shares of common stock, which includes 1,357 restricted stock units that can convert into shares upon vesting, and held 79,300 stock options outstanding.
The filing notes that the transaction was carried out under a Rule 10b5‑1 trading plan adopted on March 14, 2025. This plan is a pre-arranged, automatic trading program that was put in place when the director stated they were not aware of any material nonpublic information about Life360.
A Form 144 notice indicates an intended sale of 7,930 shares of common stock of LIF through Fidelity Brokerage Services LLC, with an aggregate market value of 491,501.40. The planned sale is listed for 01/13/2026 on the NASDAQ exchange.
The shares to be sold were acquired on 01/13/2026 by exercising an option that was originally granted on 04/12/2022, with the purchase price paid in cash. The filing also shows that Charles Prober has sold three prior blocks of 7,930 common shares during the past three months, with gross proceeds of 818,376.00, 610,054.90, and 541,619.00.
Hyperion Asset Management Limited filed a Schedule 13G reporting a significant passive ownership stake in Life360, Inc. common stock.
The firm reports beneficial ownership of 7,167,533 Life360 common shares, representing 9.14% of the class as of the event date. Hyperion has sole power to vote and dispose of all these shares, with no shared voting or dispositive power.
Hyperion states the securities were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Life360, indicating a passive institutional investment position.
Life360, Inc. director reported an insider transaction involving stock options and common shares. On 12/15/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares of common stock at $68.3 per share under transaction codes M and S.
After these transactions, the director beneficially owned 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and held 87,230 stock options at an exercise price of $11.18 per share. The filing states the trades were made under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, and also corrects previously misreported vesting terms for the stock option.
Life360, Inc. Chief Financial Officer Russell John Burke reported an option exercise and related share holdings update. On 12/15/2025, he exercised a stock option to buy 2,500 shares of Life360 common stock at an exercise price of $3.58 per share, classified as transaction code "M". Following this transaction, he beneficially owned 90,754 shares directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust.
The directly held amount includes 72,230 restricted stock units, each representing a contingent right to receive one share of common stock upon vesting. After the exercise, Burke also held 431,514 stock options directly, and the reported option is noted as fully vested and exercisable with an expiration date of 05/19/2030.
Life360, Inc. director John Coghlan reported an insider transaction involving stock options and common stock. On 12/12/2025, he acquired 920 shares of common stock through the exercise of a stock option with an exercise price of $2.15, reflected with transaction code "M".
After the transaction, he beneficially owns 2,592 shares directly, plus 10,737 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. His derivative holdings include 142,306 stock options. The footnotes state that 1,672 directly held shares were transferred to the John Coghlan Living Trust under an exemption, that 2,592 direct holdings include 1,672 restricted stock units, and that the reported stock option is fully vested and exercisable.
Life360, Inc. director John Coghlan reported sales, transfers and a charitable gift of company common stock. On 12/05/2025, the John Coghlan Living Trust sold 2,025 shares at a weighted average price of $76.82 and 1,100 shares at a weighted average price of $77.96, in each case under a Rule 10b5-1 trading plan adopted on December 6, 2024.
On 12/09/2025, he made a bona fide gift of 3,045 shares to a donor-advised fund for charitable purposes and transferred 3,045 shares between the John Coghlan Living Trust and The John Philip Coghlan 2025 Grantor Retained Annuity Trust in transactions described as exempt under Rule 16a-13.
Following these transactions, he beneficially owns 3,344 shares directly, 9,065 shares through the John Coghlan Living Trust and 55,494 shares through The John Philip Coghlan 2025 Grantor Retained Annuity Trust, including 1,672 restricted stock units that each represent one share upon vesting.
Life360, Inc.'s Chief Financial Officer reported a tax-related share withholding. On 12/04/2025, the issuer withheld 9,978 shares of common stock at $75.02 per share to satisfy income tax withholding and remittance obligations arising from the vesting and net settlement of previously granted restricted stock units, rather than an open-market sale.
After this transaction, the officer beneficially owned 88,254 shares of Life360 common stock directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust. These holdings also include 72,230 restricted stock units previously granted, each representing a contingent right to receive one share of common stock upon vesting.
Life360, Inc. reported that one of its directors sold common stock in the company. On 12/03/2025, the director sold 15,000 shares of Life360 common stock at a weighted average price of $74.19 per share, with individual trade prices ranging from $74.13 to $74.46. After this transaction, the director beneficially owns 56,809 shares indirectly through the Goines Wong Living Trust and 6,070 shares directly. The direct holdings include 2,339 restricted stock units, each representing the right to receive one share of common stock upon vesting.
Life360, Inc. (LIF) CEO and director reports a small stock sale under a preset trading plan. On 11/24/2025, the reporting person sold 4,546 shares of Life360 common stock at a price of $76.1 per share, coded as an "S" transaction. This sale was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024, which provides for automatic sales based on predetermined criteria and was put in place when the insider was not aware of material nonpublic information.
After this transaction, the insider beneficially owns 324,827 shares of Life360 common stock, including 222,277 restricted stock units that each represent a contingent right to receive one share upon vesting.